Search
Displaying results 3421 - 3430 of 3481 in total
Diisopromine
go.drugbank.com/drugs/DB13476ExperimentalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesBencyclane
go.drugbank.com/drugs/DB13488ExperimentalA vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesAcefylline
go.drugbank.com/drugs/DB13573ExperimentalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 SubstratesMetopimazine
go.drugbank.com/drugs/DB13591InvestigationalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesIpriflavone
go.drugbank.com/drugs/DB13618InvestigationalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP1A2 InhibitorsIoglicic acid
go.drugbank.com/drugs/DB13701ExperimentalCategories: X-Ray Contrast Media, Iodinated, Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast MediaTerodiline
go.drugbank.com/drugs/DB13725ExperimentalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesHalometasone
go.drugbank.com/drugs/DB13728InvestigationalCategories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersDeflazacort
go.drugbank.com/drugs/DB11921ApprovedDeflazacort, also known as Emflaza, is a corticosteroid prodrug used as an agent to manage Duchenne Muscular Dystrophy (DMD). It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA. Duchenne Muscular Dyst...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Inducers